HUP0104255A3
(en )
2002-12-28
An pharmaceutical composition suitable for inhalation
SG79255A1
(en )
2001-03-20
Pharmaceutical formulations
HUP0103507A3
(en )
2002-05-28
Pharmaceutical compositions comprising 2-quinolones
PL343627A1
(en )
2001-08-27
Medicinal compositions
AU4143999A
(en )
1999-12-06
Oral composition comprising capsules
PL339461A1
(en )
2000-12-18
Orally administered compositions containing levosimendane
GB9809213D0
(en )
1998-07-01
Pharmaceutical compositions
HUP0002198A3
(en )
2001-10-29
Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate
HU9800573D0
(en )
1998-05-28
Rapamycin formulations for oral administration
AU2564399A
(en )
1999-08-16
Isoflavanoid formulations for oral administration
HU9500618D0
(en )
1995-04-28
Oral pharmaceutical compositions
IL142534A0
(en )
2002-03-10
Pharmaceutical compositions containing an antigen-adjuvent
EP0953359A4
(en )
2001-12-19
Pharmaceutical composition for oral administration
ZA985095B
(en )
1999-12-13
Rapamycin formulations for oral administration.
GB9802472D0
(en )
1998-04-01
Pharmaceutical compositions
SI0973515T1
(en )
2003-06-30
Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
GB9806487D0
(en )
1998-05-27
Pharmaceutical compositions
ZA974125B
(en )
1998-11-13
Oral pharmaceutical compositions
HUP0101012A3
(en )
2002-12-28
Pharmaceutical composition for oral administration
GB9711046D0
(en )
1997-07-23
Oral pharmaceutical compositions
ZA976144B
(en )
1999-01-11
Oral pharmaceutical compositions
SI0971879T1
(en )
2002-06-30
Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate
IL137209A0
(en )
2001-07-24
Pharmaceutical compositions comprising disulfiram
GB9805931D0
(en )
1998-05-13
Pharmaceutical formulations
GB9817429D0
(en )
1998-10-07
Pharmaceutical formulations